Oracle Investment Management’s Antares Pharma, Inc. ATRS Stock Holding History

Oracle Investment Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,720,000	Closed	-$7.05M	–	41
2022 Q1	$7.05M	Hold	1,720,000	–	–	1.39%	12
2021 Q4	$6.14M	Sell	1,720,000 -180,000	-9%	-$630K	0.87%	15
2021 Q3	$6.92M	Hold	1,900,000	–	–	0.86%	16
2021 Q2	$8.28M	Hold	1,900,000	–	–	1.14%	15
2021 Q1	$7.81M	Hold	1,900,000	–	–	1.17%	15
2020 Q4	$7.58M	Buy	1,900,000 +200,434	+12%	+$648K	0.95%	10
2020 Q3	$4.59M	Hold	1,699,566	–	–	0.6%	11
2020 Q2	$4.67M	Buy	1,699,566 +472,452	+39%	+$1.32M	0.59%	12
2020 Q1	$2.9M	Buy	1,227,114 +538,877	+78%	+$1.83M	0.86%	11
2019 Q4	$3.23M	Buy	688,237 +400,000	+139%	+$1.64M	0.61%	13
2019 Q3	$964K	Buy	+288,237	New	+$949K	0.24%	17

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Oracle Investment Management's ATRS Position: Q2 2022 in Review

Oracle Investment Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 1,720,000 shares — an estimated $7.05M sold.

Oracle Investment Management first reported a position in ATRS in Q3 2019 and held it in 11 quarters. The position peaked at $8.28M in Q2 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Oracle Investment Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Oracle Investment Management sold 1,720,000 Antares Pharma, Inc. shares in Q2 2022, an estimated $7.05M.
Oracle Investment Management first reported a position in Antares Pharma, Inc. in Q3 2019 and held it in 11 quarters.
Oracle Investment Management's Antares Pharma, Inc. position peaked at $8.28M in Q2 2021.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Oracle Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.